NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

數位治療市場:現狀的分析與預測(2021年∼2027年)

Digital Therapeutics Market: Current Analysis and Forecast (2021-2027)

出版商 UnivDatos Market Insights Pvt Ltd 商品編碼 1008374
出版日期 內容資訊 英文 212 Pages
商品交期: 最快1-2個工作天內
價格
數位治療市場:現狀的分析與預測(2021年∼2027年) Digital Therapeutics Market: Current Analysis and Forecast (2021-2027)
出版日期: 2021年05月31日內容資訊: 英文 212 Pages
簡介

全球數位治療需求高漲,起因於傳統的醫療通訊協定的變化,和創業投資的投資劇增。預防醫療受到高度關注,遠程醫療的技術進步,高額的醫療費削減的必要性等,成為促進全球數位治療成長的要素。

除此之外,隨著新型冠狀病毒的發生,預約陸續取消和延期治療,全球導入虛擬健康和家庭健康的技術,數位治療的需求更加高漲。

但,開發中國家對數位治療的認知度低,應用和軟體的存取受限,患者資料的安全和隱私的擔憂,不穩定的付款入口網站,來自傳統的醫療系統的抵抗等成為妨礙該市場成長的要素。

本報告提供全球數位治療市場的相關調查,市場收益,機會和趨勢,成長要素及課題,COVID-19大流行的影響,各用途、銷售管道、地區的市場分析,需求與供給,競爭情形,主要企業的簡介等資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 報告所使用的貨幣
  • 數位治療市場調查範圍

第2章 調查手法或前提條件

  • 數位治療市場調查手法
    • 數位治療市場主要目的

第3章 市場摘要

第4章 摘要整理

第5章 數位治療部門主要的Start-Ups

第6章 日冕禍的數位治療

第7章 全球數位治療市場收益(2019-2027F)

第8章 各用途的市場洞察

  • 治療/照護相關用途
    • 糖尿病
    • 中樞神經系統障礙
    • 戒煙
    • 慢性呼吸疾病
    • 肌肉骨骼系統障礙
    • 心血管障礙
    • 腸胃疾病
    • 復健和患者照護
    • 其他治療/照護用途
  • 預防用途
    • 前糖尿病
    • 肥胖
    • 營養
    • 生活方式管理
    • 其他的用途

第9章 各銷售管道的市場洞察

  • B2B
    • 付款者
    • 僱用者
    • 供應商
    • 製藥企業
    • 其他
  • B2C
    • 看護者
    • 患者

第10章 各地區的市場洞察

  • 北美的數位治療市場
    • 美國
    • 加拿大
    • 北美
  • 歐洲的數位治療市場
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 亞太地區的數位治療市場
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他全球數位治療市場

第11章 數位治療市場市場動態

  • 市場成長要素
  • 市場課題
  • 影響分析

第12章 數位治療市場機會

第13章 數位治療市場趨勢

第14章 法律及法律規範

第15章 需求與供給側分析

  • 需求端分析
  • 供應端分析
    • 主要產品的銷售
    • 主要商務夥伴關係
    • 主要商務的擴大,投資及出售
    • 主要的合併和收購

第16章 價值鏈分析

第17章 競爭模式

  • 波特的五力分析
  • 競爭情形
    • 企業佔有率:各收益

第18章 企業概要

  • Fitbit, Inc
  • Omada Health
  • Medtronic
  • Livongo Health
  • Pear Therapeutics
  • Propeller Health
  • Virta Health
  • 2morrow
  • Proteus Digital Health
  • Kaia Health

第19章 免責聲明

目錄
Product Code: UMHE21230

Digital therapeutics is a subclass of digital health delivering the evidence-based therapeutic intervention to patients via high-quality Applications and Software to treat, prevent or manage a wide range of physical, mental, and behavioral health conditions. It utilizes digital health technologies and represents a distinct category of evidence-based products within the broader digital health landscape.

Digital therapeutics focuses on those conditions which are poorly addressed by the healthcare system today, including various chronic diseases and neurological disorders. They support patient's healthcare journey and provide patient's health data to clinicians and caregivers enabling them to personalize their treatment and meet all the patient's needs to avoid any complications. In addition to this, it also enables patients to take control of their care alongside the physicians and caregivers

The rising worldwide demand for digital therapeutics is because of the changing traditional medical protocols and upsurge in venture capital investments. The increased focus on preventive healthcare, technological advancement in remote healthcare, and the need to reduce surging medical costs are some factors driving the growth of digital therapeutics across the world. In addition to this, the worldwide adoption of virtual and home health technologies owing to the number of canceled appointments and deferred care amidst the novel coronavirus outbreak has further augmented the worldwide demand for digital therapeutics. However, some of the restraints in the market include lack of awareness and limited accessibility to digital therapeutics applications/software in developing countries, patient data security and privacy concerns, unstable payment portals, and resistance from conventional healthcare system are impeding the growth of this market all over the world

Based on applications, the market is divided into treatment/care-related applications and preventive applications. The treatment/care-related applications are further sub-segmented based on the type of diseases including diabetes, central nervous system disorders, smoking cessation, chronic respiratory diseases, musculoskeletal disorders, cardiovascular disorders, gastrointestinal diseases, rehabilitation & patient care, and others. In contrast, preventive applications are sub-segmented into prediabetes, obesity, nutrition, lifestyle management, and others.

Treatment/care-related applications dominated the market over preventive applications owing to the surge in incidences of chronic diseases coupled with high healthcare costs and their ability to treat various chronic and other lifestyle diseases at a lower cost

Based on sales channels, the digital therapeutics market is fragmented into business-to-business (B2B) and business-to-customer (B2C) segments. The B2B segment is further sub-segmented into payers, employers, providers, pharmaceutical companies, and others. The B2C segment is also further sub-segmented into caregivers and patients

The B2B segment holds a major share in the market and is expected to grow at the highest CAGR of the digital therapeutics market owing to the rising awareness among payers, employers, providers and various pharmaceutical companies across the world

For a better understanding of the market adoption of digital therapeutics, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India and Rest of APAC), and Rest of World. North America constitutes the largest market for the digital therapeutics industry and generated revenue of USD XX million in 2020 owing to the government support for advanced research and development in the field of digital therapeutics and increasing awareness regarding the benefits offered by them. However, the Asia Pacific region is also expected to grow at the highest CAGR during the forecast period

Some of the major players operating in the market include Fitbit Inc., Medtronic, Omada health, Livongo health, Proteus digital health, pear therapeutics, Propeller health, Virta health, 2morrow, Kaia health, etc. Several M&A's along with partnerships have been undertaken by these players to boost their presence in different regions

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1 Market Definitions
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stake Holders
  • 1.5 Currency Used in Report
  • 1.6 Scope of the Digital Therapeutics Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Digital Therapeutics Market
    • 2.1.1 Main Objective of the Digital Therapeutics Market

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 TOP START-UPS UNDER DIGITAL THERAPEUTICS SECTOR

6 DIGITAL THERAPEUTICS AMID COVID-19

7 GLOBAL DIGITAL THERAPEUTICS MARKET REVENUE (USD BN), 2019-2027F

8 MARKET INSIGHTS BY APPLICATION

  • 8.1 Treatment/Care Related Applications
    • 8.1.1 Diabetes
    • 8.1.2 Central Nervous System Disorders
    • 8.1.3 Smoking Cessation
    • 8.1.4 Chronic Respiratory Diseases
    • 8.1.5 Musculoskeletal Disorders
    • 8.1.6 Cardiovascular Disorders
    • 8.1.7 Gastrointestinal Diseases
    • 8.1.8 Rehabilitation & Patient Care
    • 8.1.9 Other Treatment/Care Applications
  • 8.2 Preventive Applications
    • 8.2.1 Prediabetes
    • 8.2.2 Obesity
    • 8.2.3 Nutrition
    • 8.2.4 Lifestyle Management
    • 8.2.5 Other Applications

9 MARKET INSIGHTS BY SALES CHANNELS

  • 9.1 B2B
    • 9.1.1 Payers
    • 9.1.2 Employers
    • 9.1.3 Providers
    • 9.1.4 Pharmaceutical Companies
    • 9.1.5 Others
  • 9.2 B2C
    • 9.2.1 Caregivers
    • 9.2.2 Patients

10 MARKET INSIGHTS BY REGION

  • 10.1 North America Digital Therapeutics Market
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Rest of North America
  • 10.2 Europe Digital Therapeutics Market
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 United Kingdom
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Rest of Europe
  • 10.3 Asia Pacific Digital Therapeutics Market
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 Rest of Asia Pacific
  • 10.4 Rest of World Digital Therapeutics Market

11 DIGITAL THERAPEUTICS MARKET DYNAMICS

  • 11.1 Market Drivers
  • 11.2 Market Challenges
  • 11.3 Impact Analysis

12 DIGITAL THERAPEUTICS MARKET OPPORTUNITIES

13 DIGITAL THERAPEUTICS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

  • 15.1 Demand Side Analysis
  • 15.2 Supply Side Analysis
    • 15.2.1 Top Product Launches
    • 15.2.2 Top Business Partnerships
    • 15.2.3 Top Business Expansions, Investments and Divestitures
    • 15.2.4 Top Merger and Acquisitions

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1 Porter's Five Forces Analysis
    • 17.1.1 Bargaining power of Supplier
    • 17.1.2 Bargaining power of Buyer
    • 17.1.3 Industry Rivalry
    • 17.1.4 Availability of Substitute
    • 17.1.5 Threat of new Entrants
  • 17.2 Competitive Landscape
    • 17.2.1 Company Shares, By Revenue

18 COMPANY PROFILED

  • 18.1 Fitbit, Inc
  • 18.2 Omada Health
  • 18.3 Medtronic
  • 18.4 Livongo Health
  • 18.5 Pear Therapeutics
  • 18.6 Propeller Health
  • 18.7 Virta Health
  • 18.8 2morrow
  • 18.9 Proteus Digital Health
  • 18.10 Kaia Health

19 DISCLAIMER